keyword
https://read.qxmd.com/read/38694323/leiomyosarcoma-of-stomach-extending-to-gastroesophageal-junction-and-distal-esophagus-as-a-rare-cause-of-dysphagia-a-case-report
#41
Lilamani Rajthala, Sagar Gyawali, Sabin Banmala, Surendra Shah
INTRODUCTION AND IMPORTANCE: Gastric leiomyosarcoma is a rare malignant tumor among the primary gastric carcinomas. Among the different common presentations, dysphagia is an uncommon presentation of gastric leiomyosarcoma. CASE PRESENTATION: A 29-year-old female presented with complaints of progressive dysphagia for 1 year associated with vomiting, significant weight loss, and anorexia for 6 months. On blood investigations, she had anemia, hypokalemia, prerenal acute kidney injury, and unconjugated hyperbilirubinemia...
May 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38693424/long-non-coding-rna-loxl1-as1-a-potential-biomarker-and-therapeutic-target-in-human-malignant-tumors
#42
REVIEW
Xiao-Ping Fu, Chun-Yan Ji, Wen-Qian Tang, Ting-Ting Yu, Lei Luo
Long non-coding RNAs (lncRNAs) are transcripts that contain more than 200 nucleotides. Despite their inability to code proteins, multiple studies have identified their important role in human cancer through different mechanisms. LncRNA lysyl oxidase like 1 antisense RNA 1 (LOXL1-AS1), a newly discovered lncRNA located on human chromosome 15q24.1, has recently been shown to be involved in the occurrence and progression of various malignancies, such as colorectal cancer, gastric cancer, hepatocellular carcinoma, prostate cancer, non-small cell lung cancer, ovarian cancer, cervical cancer, breast cancer, glioma, thymic carcinoma, pancreatic carcinoma...
May 2, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38691201/conversion-surgery-for-gastric-remnant-cancer-with-liver-metastasis-after-nivolumab-combination-chemotherapy-achieving-pathological-complete-response-a-case-report-and-literature-review
#43
JOURNAL ARTICLE
Kaori Katsumata, Yosuke Morimoto, Junya Aoyama, Toru Yamada, Yusuke Katsuki, Ryo Nishiyama, Tomohisa Egawa
BACKGROUND: Nivolumab combination chemotherapy has recently emerged as a potential first-line treatment for patients with unresectable or metastatic gastric cancer (GC). Further research has indicated that R0 resection by conversion surgery could be an effective treatment strategy to improve overall survival. However, there have been limited reports on the successful application of conversion surgery following combination chemotherapy achieving pathological complete response (pCR) in cases of advanced gastric remnant cancer with liver metastasis...
May 1, 2024: Surgical Case Reports
https://read.qxmd.com/read/38689671/metastatic-occult-primary-lobular-breast-cancer-a-case-report
#44
Athanasios Pouptsis, Julia Cano Gimeno, Carmen Martinez Rubio, Marta Bañuls Marrades, Patricia Olivan Sasot
Breast cancer is the most common malignancy diagnosed in women. Invasive lobular breast cancer (ILC) is the second most common histologic subtype after invasive ductal carcinoma. Metastatic occult primary breast cancer, although rare, is a well-known clinical entity that usually presents with axillary lymphadenopathy without a detectable breast tumour. A perimenopausal woman in her 50s presented with abdominal pain, fatigue, and weight loss. Imaging showed peritoneal carcinomatosis with ascites, ovarian masses, and a lesion in the ascending colon...
April 2024: Curēus
https://read.qxmd.com/read/38686193/case-report-a-germline-chek1-c-613-2t-c-leads-to-a-splicing-error-in-a-family-with-multiple-cancer-patients
#45
Jun Qian, Min Peng, Yanan Li, Wei Liu, Xinwei Zou, Huafei Chen, Sujuan Zhou, Sheng Xiao, Jinhua Zhou
BACKGROUND: Genome instability plays a crucial role in promoting tumor development. Germline mutations in genes responsible for DNA repair are often associated with familial cancer syndromes. A noticeable exception is the CHEK1 gene. Despite its well-established role in homologous recombination, germline mutations in CHEK1 are rarely reported. CASE PRESENTATION: In this report, we present a patient diagnosed with ovarian clear cell carcinoma who has a family history of cancer...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38686189/role-of-spry4-in-health-and-disease
#46
REVIEW
Hao Pan, Renjie Xu, Yong Zhang
SPRY4 is a protein encoding gene that belongs to the Spry family. It inhibits the mitogen-activated protein kinase (MAPK) signaling pathway and plays a role in various biological functions under normal and pathological conditions. The SPRY4 protein has a specific structure and interacts with other molecules to regulate cellular behavior. It serves as a negative feedback inhibitor of the receptor protein tyrosine kinases (RTK) signaling pathway and interferes with cell proliferation and migration. SPRY4 also influences inflammation, oxidative stress, and cell apoptosis...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38685845/ebv-associated-gastric-cancer-an-in-situ-hybridization-assay-on-tissue-microarray-a-multi-region-study-from-four-major-provinces-of-iran
#47
JOURNAL ARTICLE
Maryam Abolhasani, Ata Ollah Mohseni, Ramin Shakeri, Ali Khavanin, Mehrdad Khajehei, Abbasali Omidi, Bita Geramizadeh, Ensieh Shafigh, Farshad Naghshvar, Payam Fathizadeh, Leyla Taghizadehgan, Atoosa Gharib, Margaret L Gulley, Sanford M Dawsey, Reza Malekzadeh, Charles S Rabkin, Mohammad Vasei
BACKGROUND: Gastric cancer is the fourth leading cause of cancer-related deaths in the world. The identification of gastric cancer subtypes related to recognizable microbial agents may play a pivotal role in the targeted prevention and treatment of this cancer. The current study is conducted to define the frequency of Epstein-Barr virus (EBV) infection in gastric cancers of four major provinces, with different incidence rates of gastric cancers, in Iran. METHODS: Paraffin blocks of 682 cases of various types of gastric cancer from Tehran, South and North areas of Iran were collected...
April 1, 2024: Archives of Iranian Medicine
https://read.qxmd.com/read/38681129/characteristics-of-early-gastric-tumors-with-different-differentiation-and-predictors-of-long-term-outcomes-after-endoscopic-submucosal-dissection
#48
JOURNAL ARTICLE
Hong-Yi Zhu, Jie Wu, Yuan-Miao Zhang, Fang-Lan Li, Jin Yang, Bin Qin, Jiong Jiang, Ning Zhu, Meng-Yao Chen, Bai-Cang Zou
BACKGROUND: Gastric cancer is a common malignant tumor of the digestive tract, and endoscopic submucosal dissection (ESD) is the preferred treatment for early-stage gastric cancer. The analysis of the epidemiological characteristics of gastric mucosal tumors with different differentiation degrees and the influencing factors of long-term ESD efficacy may have certain significance for revealing the development of gastric cancer and ESD. AIM: To analyze the features of gastric mucosal tumors at different differentiation levels, and to explore the prognostic factors of ESD...
April 14, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38678993/gastric-cancer-after-laparoscopic-adjustable-gastric-banding-a-case-report
#49
Masaki Kanno, Akira Umemura, Shigeaki Baba, Haruka Nikai, Ryo Sugimoto, Akira Sasaki
INTRODUCTION: Gastric cancer occurring after bariatric and metabolic surgeries is rare. We report a case of gastric cancer that developed at 14 years after laparoscopic adjustable gastric banding. PRESENTATION OF CASE: The patient was an obese 81-year-old woman who underwent LAGB at 14 years prior when her body mass index was 35.3 kg/m2 . Anemia was noted during a visit to her family clinic. Subsequent esophagogastroduodenoscopy revealed a type 5 lesion (Macroscopic Classification of the Gastric Cancer in Japanese Classification of Gastric Carcinoma, The 15th Edition) near the greater curvature of the posterior wall of the gastric antrum...
April 27, 2024: International Journal of Surgery Case Reports
https://read.qxmd.com/read/38677591/prognostic-effect-of-tertiary-lymphoid-structures-in-epstein-barr-virus-associated-gastric-carcinomas-measured-by-digital-image-analysis
#50
JOURNAL ARTICLE
Yun Joo Cho, Inwoo Hwang, Suho Park, Somin Lee, So Young Kang, Min-Ji Kim, Soomin Ahn, Kyoung-Mee Kim
Epstein-Barr virus-associated gastric carcinoma (EBVaGC) is characterized by prominent tumor-infiltrating lymphocytes (TIL) and has a favorable prognosis. Tertiary lymphoid structures (TLS), characterized by ectopic aggregated lymphocytes with high endothelial venules (HEV), are associated with favorable outcomes in various solid tumors. We hypothesized that EBVaGC, characterized by intense TIL, may be closely associated with TLS or HEV. To test this hypothesis, we digitally analyzed the TLS, HEV, and TIL in 73 surgically resected advanced EBVaGCs...
April 25, 2024: Laboratory Investigation; a Journal of Technical Methods and Pathology
https://read.qxmd.com/read/38672634/early-onset-gastrointestinal-malignancies-an-investigation-into-a-rising-concern
#51
REVIEW
Aayush Vishwanath, Shreyas Krishna, Albert P Manudhane, Phil A Hart, Somashekar G Krishna
There is growing recognition of early-onset gastrointestinal (GI) malignancies in young adults < 50 years of age. While much of the literature has emphasized colorectal cancer, these also include esophageal, gastric, liver, pancreatic, and biliary tract malignancies. Various factors, including lifestyle, hereditary, and environmental elements, have been proposed to explain the rising incidence of GI malignancies in the younger population. This review aims to provide an overview of the recent literature, including global trends and information regarding genetic and environmental risk factors...
April 18, 2024: Cancers
https://read.qxmd.com/read/38670589/the-important-role-of-gpx1-and-nf-%C3%AE%C2%BAb-signaling-pathway-in-human-gastric-cancer-implications-for-cell-proliferation-and-invasion
#52
JOURNAL ARTICLE
Byeong Il Jang, Ji Yoon Jung, Sung Ae Koh, Kyung Hee Lee
BACKGROUND/AIM: Glutathione peroxidases (GPXs) are crucial antioxidant enzymes, counteracting reactive oxygen species (ROS). GPX overexpression promotes proliferation and invasion in cancer cells. Glutathione peroxidase-1 (GPX1), the most abundant isoform, contributes to invasion, migration, cisplatin resistance, and proliferation in various cancers. Nuclear factor-kappa B (NF-[Formula: see text]B) participates in cell proliferation, apoptosis, and tumor progression. The inhibition of NF-[Formula: see text]B expression reduces the malignancy of esophageal squamous cell carcinoma...
April 26, 2024: Cancer Genomics & Proteomics
https://read.qxmd.com/read/38665494/retraction-salidroside-inhibits-the-proliferation-and-migration-of-gastric-carcinoma-cells-and-tumor-growth-via-the-activation-of-ers-dependent-autophagy-and-apoptosis
#53
Wei Yan, Kai Li, Amin Buhe, Tianxiong Li, Peirong Tian, Jun Hong
[This retracts the article DOI: 10.1039/C9RA00044E.].
April 22, 2024: RSC Advances
https://read.qxmd.com/read/38665055/the-impact-of-infectious-mononucleosis-history-on-the-risk-of-developing-lymphoma-and-nasopharyngeal-carcinoma-a-retrospective-large-scale-cohort-study-using-national-health-insurance-data-in-south-korea
#54
JOURNAL ARTICLE
So Hee Kang, Yun-Hee Lee, Jun-Pyo Myong, Minsu Kwon
PURPOSE: This study aimed to assess the long-term risks associated with a history of infectious mononucleosis (IM), primarily caused by the Epstein-Barr virus (EBV). Specifically analyzing the potential increase in developing nasopharyngeal cancer (NPC) and lymphoma in patients with a history of IM and exploring the prevalence of other EBV-associated conditions. MATERIALS AND METHODS: The Korean National Health Insurance Service (NHIS) database was utilized for a retrospective analysis, covering data from 2002 to 2021...
April 23, 2024: Cancer Research and Treatment: Official Journal of Korean Cancer Association
https://read.qxmd.com/read/38663962/emerging-trends-in-gastrointestinal-cancers-targeting-developmental-pathways-in-carcinogenesis-and-tumor-progression
#55
REVIEW
Afza Ahmad, Rohit Kumar Tiwari, Saleha Siddiqui, Muskan Chadha, Ratnakar Shukla, Vivek Srivastava
Gastrointestinal carcinomas are a group of cancers associated with the digestive system and its accessory organs. The most prevalent cancers related to the gastrointestinal tract are colorectal, gall bladder, gastric, hepatocellular, and esophageal cancers, respectively. Molecular aberrations in different signaling pathways, such as signal transduction systems or developmental pathways are the chief triggering mechanisms in different cancers Though a massive advancement in diagnostic and therapeutic interventions results in improved survival of patients with gastrointestinal cancer; the lower malignancy stages of these carcinomas are comparatively asymptomatic...
2024: International Review of Cell and Molecular Biology
https://read.qxmd.com/read/38663178/somatic-mutations-that-affect-early-genetic-progression-and-immune-microenvironment-in-gastric-carcinoma
#56
JOURNAL ARTICLE
Xiaoxiao Li, Zirui Tang, Zhaopeng Li, Zhao Li, Ping Zhao, Yi Song, Kexin Yang, Zihan Xia, Yinan Wang, Dong Guo
Gastric carcinoma (GC) is a high heterogeneity and malignant tumor with a poor prognosis. The current implementation of immunotherapy in GC is limited due to the insufficient exploration of immune-related mutations and speculated early mutation events. Therefore, we performed whole-exome sequencing on 40 patients with GC to explore their genetic characteristics, shedding light on the order of genetic events, somatic mutations impacting the immune microenvironment, and potential biomarkers for immunotherapy...
April 14, 2024: Pathology, Research and Practice
https://read.qxmd.com/read/38662248/interleukin-33-supports-squamous-cell-carcinoma-growth-via-a-dual-effect-on-tumour-proliferation-migration-and-invasion-and-t-cell-activation
#57
JOURNAL ARTICLE
Graziela Perri, Vanessa Garcia Vilas Boas, Maria Renata Sales Nogueira, Edgard José Franco Mello Júnior, Ana Lucia Coelho, Edwin M Posadas, Cory Hogaboam, Karen A Cavassani, Ana Paula Campanelli
Interleukin (IL)-33 is an important cytokine in the tumour microenvironment; it is known to promote the growth and metastasis of solid cancers, such as gastric, colorectal, ovarian and breast cancer. Our group demonstrated that the IL-33/ST2 pathway enhances the development of squamous cell carcinoma (SCC). Conversely, other researchers have reported that IL-33 inhibits tumour progression. In addition, the crosstalk between IL-33, cancer cells and immune cells in SCC remains unknown. The aim of this study was to investigate the effect of IL-33 on the biology of head and neck SCC lines and to evaluate the impact of IL-33 neutralisation on the T cell response in a preclinical model of SCC...
April 25, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38661583/sarcina-ventriculi-an-unexpected-herald-of-gastric-carcinoma
#58
JOURNAL ARTICLE
Filip Skowronek, Aleksandra Ciarka, Weronika Łyzińska, Michał Piątek, Rafał Pęksa, Michał Kunc
No abstract text is available yet for this article.
April 25, 2024: Polish Archives of Internal Medicine
https://read.qxmd.com/read/38660631/effectiveness-and-tolerability-of-programmed-cell-death-protein-1-inhibitor-chemotherapy-compared-to-chemotherapy-for-upper-gastrointestinal-tract-cancers
#59
JOURNAL ARTICLE
Xiao-Min Zhang, Ting Yang, Ying-Ying Xu, Bao-Zhong Li, Wei Shen, Wen-Qing Hu, Cai-Wen Yan, Liang Zong
BACKGROUND: The combination of programmed cell death protein-1 (PD-1) inhibitor and chemotherapy is approved as a standard first- or second-line treatment in patients with advanced oesophageal or gastric cancer. However, it is unclear whether this combination is superior to chemotherapy alone. AIM: To assess the comparative effectiveness and tolerability of combining PD-1 inhibitors with chemotherapy vs chemotherapy alone in patients with advanced gastric cancer, gastroesophageal junction (GEJ) cancer, or oesophageal carcinoma...
April 15, 2024: World Journal of Gastrointestinal Oncology
https://read.qxmd.com/read/38660300/a-novel-web-based-dynamic-prognostic-nomogram-for-gastric-signet-ring-cell-carcinoma-a-multicenter-population-based-study
#60
MULTICENTER STUDY
Yujuan Jiang, Haitao Hu, Xinxin Shao, Weikun Li, Yiming Lu, Jianwei Liang, Yantao Tian
BACKGROUND: Gastric signet ring cell carcinoma (GSRCC) is a rare and highly malignant disease with a poor prognosis. To assess the overall survival (OS) and cancer-specific survival (CSS) of patients with GSRCC, prognostic nomograms were developed and validated using common clinical factors. METHODS: This retrospective cohort study included patients diagnosed with GSRCC between 2011 and 2018 from the National Cancer Center (n = 1453) and SEER databases (n = 2745)...
2024: Frontiers in Immunology
keyword
keyword
56366
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.